Selective Suppression of Excessive GluN2C Expression Rescues Early Epilepsy in a Tuberous Sclerosis Murine Model

Overview

Journal Nat Commun

Specialty Biology

Date 2014 Aug 2

PMID 25081057

Citations 51

Authors

N Lozovaya

S Gataullina

T Tsintsadze

V Tsintsadze

E Pallesi-Pocachard

M Minlebaev

N A Goriounova

E Buhler

F Watrin

S Shityakov

A J Becker

A Bordey

M Milh

D Scavarda

C Bulteau

G Dorfmuller

O Delalande

A Represa

C Cardoso

O Dulac

Y Ben-Ari

N Burnashev

Affiliations

Soon will be listed here.

Abstract

Tuberous sclerosis complex (TSC), caused by dominant mutations in either TSC1 or TSC2 tumour suppressor genes is characterized by the presence of brain malformations, the cortical tubers that are thought to contribute to the generation of pharmacoresistant epilepsy. Here we report that tuberless heterozygote Tsc1(+/-) mice show functional upregulation of cortical GluN2C-containing N-methyl-D-aspartate receptors (NMDARs) in an mTOR-dependent manner and exhibit recurrent, unprovoked seizures during early postnatal life (<P19). Seizures are generated intracortically in the granular layer of the neocortex. Slow kinetics of aberrant GluN2C-mediated currents in spiny stellate cells promotes excessive temporal integration of persistent NMDAR-mediated recurrent excitation and seizure generation. Accordingly, specific GluN2C/D antagonists block seizures in Tsc1(+/-) mice in vivo and in vitro. Likewise, GluN2C expression is upregulated in TSC human surgical resections, and a GluN2C/D antagonist reduces paroxysmal hyperexcitability. Thus, GluN2C receptor constitutes a promising molecular target to treat epilepsy in TSC patients.

Citing Articles

Iconography of abnormal non-neuronal cells in pediatric focal cortical dysplasia type IIb and tuberous sclerosis complex.

Zhang J, Argueta D, Tong X, Vinters H, Mathern G, Cepeda C Front Cell Neurosci. 2025; 18():1486315.

PMID: 39835291 PMC: 11743721. DOI: 10.3389/fncel.2024.1486315.

Mechanisms of Action Underlying Conductance-Modifying Positive Allosteric Modulators of the NMDA Receptor.

Ullman E, Perszyk R, Paladugu S, Fritzemeier R, Akins N, Jacobs L Mol Pharmacol. 2024; 106(6):334-353.

PMID: 39443157 PMC: 11585258. DOI: 10.1124/molpharm.124.001019.

Genotypic and phenotypic analysis of Korean patients with tuberous sclerosis complex.

Shin H, Lee S, Kim S, Lee J, Oh J, Ko A Neurogenetics. 2024; 25(4):471-479.

PMID: 39110368 DOI: 10.1007/s10048-024-00777-5.

Epilepsy in Patients with Gliomas.

Ehara T, Ohka F, Motomura K, Saito R Neurol Med Chir (Tokyo). 2024; 64(7):253-260.

PMID: 38839295 PMC: 11304448. DOI: 10.2176/jns-nmc.2023-0299.

Functional Analysis of NMDAR Subunit Components in Postsynaptic Currents of Identified Cells and Synapses in Brain Slices.

Pineau L, Burnashev N Methods Mol Biol. 2024; 2799:139-150.

PMID: 38727906 DOI: 10.1007/978-1-0716-3830-9_8.

References

Beierlein M, Fall C, Rinzel J, Yuste R . Thalamocortical bursts trigger recurrent activity in neocortical networks: layer 4 as a frequency-dependent gate. J Neurosci. 2002; 22(22):9885-94. PMC: 6757840. View

Kandel A, Buzsaki G . Cellular-synaptic generation of sleep spindles, spike-and-wave discharges, and evoked thalamocortical responses in the neocortex of the rat. J Neurosci. 1997; 17(17):6783-97. PMC: 6573130. View

Carlen M, Meletis K, Siegle J, Cardin J, Futai K, Vierling-Claassen D . A critical role for NMDA receptors in parvalbumin interneurons for gamma rhythm induction and behavior. Mol Psychiatry. 2011; 17(5):537-48. PMC: 3335079. DOI: 10.1038/mp.2011.31. View

Chu-Shore C, Major P, Camposano S, Muzykewicz D, Thiele E . The natural history of epilepsy in tuberous sclerosis complex. Epilepsia. 2010; 51(7):1236-41. PMC: 3065368. DOI: 10.1111/j.1528-1167.2009.02474.x. View

Ghasemi M, Schachter S . The NMDA receptor complex as a therapeutic target in epilepsy: a review. Epilepsy Behav. 2011; 22(4):617-40. DOI: 10.1016/j.yebeh.2011.07.024. View

Dayas C, Smith D, Dunkley P . An emerging role for the Mammalian target of rapamycin in "pathological" protein translation: relevance to cocaine addiction. Front Pharmacol. 2012; 3:13. PMC: 3272624. DOI: 10.3389/fphar.2012.00013. View

Uhlmann E, Wong M, Baldwin R, Bajenaru M, Onda H, Kwiatkowski D . Astrocyte-specific TSC1 conditional knockout mice exhibit abnormal neuronal organization and seizures. Ann Neurol. 2002; 52(3):285-96. DOI: 10.1002/ana.10283. View

Major P, Rakowski S, Simon M, Cheng M, Eskandar E, Baron J . Are cortical tubers epileptogenic? Evidence from electrocorticography. Epilepsia. 2009; 50(1):147-54. DOI: 10.1111/j.1528-1167.2008.01814.x. View

Krystal J, Anand A, Moghaddam B . Effects of NMDA receptor antagonists: implications for the pathophysiology of schizophrenia. Arch Gen Psychiatry. 2002; 59(7):663-4. DOI: 10.1001/archpsyc.59.7.663. View

10.

Costa B, Feng B, Tsintsadze T, Morley R, Irvine M, Tsintsadze V . N-methyl-D-aspartate (NMDA) receptor NR2 subunit selectivity of a series of novel piperazine-2,3-dicarboxylate derivatives: preferential blockade of extrasynaptic NMDA receptors in the rat hippocampal CA3-CA1 synapse. J Pharmacol Exp Ther. 2009; 331(2):618-26. PMC: 2775268. DOI: 10.1124/jpet.109.156752. View

11.

Zilles K, Qu M, Kohling R, Speckmann E . Ionotropic glutamate and GABA receptors in human epileptic neocortical tissue: quantitative in vitro receptor autoradiography. Neuroscience. 2000; 94(4):1051-61. DOI: 10.1016/s0306-4522(99)00392-9. View

12.

Zeng L, Xu L, Gutmann D, Wong M . Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol. 2008; 63(4):444-53. PMC: 3937593. DOI: 10.1002/ana.21331. View

13.

Meikle L, Pollizzi K, Egnor A, Kramvis I, Lane H, Sahin M . Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: effects on mTORC1 and Akt signaling lead to improved survival and function. J Neurosci. 2008; 28(21):5422-32. PMC: 2633923. DOI: 10.1523/JNEUROSCI.0955-08.2008. View

14.

Cepeda C, Andre V, Vinters H, Levine M, Mathern G . Are cytomegalic neurons and balloon cells generators of epileptic activity in pediatric cortical dysplasia?. Epilepsia. 2005; 46 Suppl 5:82-8. DOI: 10.1111/j.1528-1167.2005.01013.x. View

15.

Fleidervish I, Binshtok A, Gutnick M . Functionally distinct NMDA receptors mediate horizontal connectivity within layer 4 of mouse barrel cortex. Neuron. 1998; 21(5):1055-65. DOI: 10.1016/s0896-6273(00)80623-6. View

16.

Curatolo P, Bombardieri R, Cerminara C . Current management for epilepsy in tuberous sclerosis complex. Curr Opin Neurol. 2006; 19(2):119-23. DOI: 10.1097/01.wco.0000218225.50807.12. View

17.

Crino P, Aronica E, Baltuch G, Nathanson K . Biallelic TSC gene inactivation in tuberous sclerosis complex. Neurology. 2010; 74(21):1716-23. PMC: 2882213. DOI: 10.1212/WNL.0b013e3181e04325. View

18.

Lefort S, Tomm C, Sarria J, Petersen C . The excitatory neuronal network of the C2 barrel column in mouse primary somatosensory cortex. Neuron. 2009; 61(2):301-16. DOI: 10.1016/j.neuron.2008.12.020. View

19.

Curatolo P, Bombardieri R, Jozwiak S . Tuberous sclerosis. Lancet. 2008; 372(9639):657-68. DOI: 10.1016/S0140-6736(08)61279-9. View

20.

Baybis M, Yu J, Lee A, Golden J, Weiner H, McKhann 2nd G . mTOR cascade activation distinguishes tubers from focal cortical dysplasia. Ann Neurol. 2004; 56(4):478-87. DOI: 10.1002/ana.20211. View